Publications Revues à Comité de Lecture 2017-21

  1. Autosomal Recessive Cardiomyopathy Presenting as Acute Myocarditis (see slide show on this topic)
  2. Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure (see slide show on this topic)
  3. Population-based study of cognitive outcomes in congenital heart defects
  4. Reliability of Peak Exercise Stroke Volume Assessment by Impedance Cardiography in Patients with Residual Right Outflow Tract Lesions After Congenital Heart Disease Repair
  5. Neurocognitive and Psychological Outcomes in Adults With Dextro-Transposition of the Great Arteries Corrected by the Arterial Switch Operation
  6. Cardiac Magnetic Resonance Myocardial Perfusion After Arterial Switch for Transposition of Great Arteries
  7. Quality of life in children participating in a non-selective INR self-monitoring VKA-education programme
  8. Cardiovascular anatomy in children with bidirectional Glenn anastomosis regarding the transcatheter Fontan completion
  9. Myocardial Stiffness Assessment Using Shear Wave Imaging in Pediatric Hypertrophic Cardiomyopathy
  10. Arterial tortuosity syndrome: 40 new  families and literature review
  11. Cardiac function and exercise adaptation in 8 children with LPIN1 mutations (to be uploaded)
  12. Pulmonary hypertension in an adolescent with end-stage-renal disease-a diagnostic challenge
  13. Preventing the risk of coronary injury in posteroseptal accessory pathway ablation in children: different strategies and advantages of fluoroscopy integrated 3D-mapping system
  14. Safety, efficacy and Management of subcutaneous treprostinil infusions in the treatment of severe pediatric pulmonary hypertension
  15. Administrative health databases for addressing emerging issues in adults with CHD: a systematic review
  16. Epithelial barrier dysfunction in Desmoglein-1 deficiency (Arrhythmogenic right ventricular Cardiomyopathy)
  17. Low-dose paediatric cardiac and thoracic computed tomography with prospective triggering: Is it possible at any heart rate?
  18. Paracetamol/Acetaminophen during pregnancy induces prenatal ductus arteriosus closure
  19. Myocardial inflammation detected by cardiac MRI in Arrhythmogenic right ventricular cardiomyopathy.pdf
  20. Analysis of HOXB1 gene in a cohort of patients with sporadic ventricular septal defect
  21. Hematopoietic Stem Cell Count Is Predictive of Vascular Event Occurrence in Children with Sickle Cell Disease
  22. Hybrid Repair of Kommerell Diverticulum in Right Aortic Arch: Anatomic Considerations
  23. Outcomes of the anatomical repair in patients with congenitally corrected transposition of the great arteries: lessons learned in a high-volume centre.
  24. Particular surgical aspects of endocarditis due to Kingella kingae with cerebral complication.
  25. Radiation exposure in transcatheter patent ductus arteriosus closure: time to tune?
  26. French national survey on infective endocarditis and the Melody™ valve in percutaneous pulmonary valve implantation.
  27. Branch Pulmonary Artery Valve Implantation Reduces Pulmonary Regurgitation and Improves Right Ventricular Size/Function in Patients With Large Right Ventricular Outflow Tracts.
  28. Transcatheter Pulmonary Valve Replacement With the Melody Valve in Small Diameter Expandable Right Ventricular Outflow Tract Conduits.
  29. Krox20 defines a subpopulation of cardiac neural crest cells contributing to arterial valves and bicuspid aortic valve.pdf
  30. Sudden Cardiovascular Arrest During Sexual Intercourse (investigator)
  31. Should We Perform an Immediate Coronary Angiogram in All Patients After Cardiac Arrest?: Insights From a Large French Registry (investigator)
  32. CD34+ Hematopoietic Stem Cell Count Is Predictive of Vascular Event Occurrence in Children with Sickle Cell Disease.pdf
  33. Long-term results of the modified Konno procedure in high-risk children with obstructive hypertrophic cardiomyopathy.pdf
  34. Anatomy of the ventricular septal defect in congenital heart defects a random association.pdf
  35. A case of reversible pulmonary arterial hypertension associated with incontinentia pigmenti.pdf
  36. Successful in utero transesophageal pacing for severe drug-resistant tachyarrhythmia.pdf.
  37. Recommendations from the Association for European Paediatric and Congenital Cardiology for clinical training in paediatric heart failure and transplantation.pdf
  38. Crossed pulmonary arteries as additional cause of dysphagia in association with right aortic arch and Kommerell diverticulum.pdf.
  39. Mechanical tachycardia of the slow pathway induced by a percutaneous tricuspid valve device.pdf
  40. Left atrial flutter after implantation of atrial septal occluder.pdf
  41. Classification of Ventricular Septal Defects for the Eleventh Iteration of the International Classification of Diseases.pdf
  42. Risk of thromboembolic complications in adult congenital heart disease - a literature review.pdf
  43. Pregnancy in Women With a Fontan Circulation A Systematic Review of the Literature.pdf
  44. Too big for echocardiography.pdf
  45. Evaluation of the relationship between ventricular end-diastolic pressure and echocardiographic measures of diastolic function in adults with a Fontan circulation.pdf
  46. Role of myocardial collagen degradation and fibrosis in right ventricle dysfunction in transposition of the great arteries after atrial switch.
  47. Transconduit puncture without per-procedural echocardiography in nonfenestrated extracardiac Fontan using a simplified approach guided by electroanatomic mapping.pdf
  48. Reduction of radiation exposure in transcatheter atrial septal defect closure- How low must we go? .pdf
  49. Paradoxical right heart failure due to persistent ductus arteriosus.pdf
  50. Assessing the risk of preterm birth for newborns with congenital heart defects conceived following infertility treatments.pdf
  51. Clinical presentation and therapeutic management of venous thrombosis in young children.pdf
  52. Nomenclature for congenital and paediatric cardiac disease- the International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Iteration of the International Classification of Diseases (ICD-11).pdf
  53. Assistance circulatoire et transplantation d organes thoraciques chez l'enfant.pdf
  54. Classification of Ventricular Septal Defects for the Eleventh Iteration of the International Classification of Diseases.pdf
  55. Projected Future Cancer Risks in Children Treated With Fluoroscopy Guided Cardiac Catheterization Procedures.pdf
  56. Pathophysiology and natural history of atrial septal defect.pdf
  1. Réadaptation cardiaque des adultes avec cardiopathies congénitales.pdf
  2. Improving Quality of Congenital Heart Disease Research in Canada: Standardizing Nomenclature Across Canada (to be uploaded)
  1. Systemic right ventricular takotsubo cardiomyopathy.pdf
  2. Mitral valve replacement with a pulmonary autograft.pdf
  3. Impact of Heparin- or Nonheparin-Coated Circuits on Platelet Function in Pediatric Cardiac Surgery.pdf

  5. A new anatomic approach of the ventricular septal defect in the interruption of the aortic arch.pdf
  6. Evaluation of septal insertion ofatrioventricular valves in fetuses by postmortem 4.7 Tesla cardiac MRI.pdf
  1. Paediatric pulmonary arterial hypertension Nice 2018.pdf
  1. Platelet-mapping assay for monitoring antiplatelet therapy during mechanical circulatory support in children - A retrospective observational study.pdf
  2. The QUALI-REHAB study rationale, design and methods.pdf
  3. Widening the landscape of heritable pulmonary hypertension mutations.pdf
  1. Accuracy of claim data in the identification and classification of adults with congenital heart diseases in electronic medical records.pdf
  2. Idiopathic, heritable and veno-occlusive pulmonary arterial hypertension in childhood computed tomography angiography features in the initial assessment of the disease.pdf
  3. Aortic angle is associated with neo-aortic root dilatation and regurgitation following arterial switch operation.pdf
  4. Perinatal intracardiac teratoma- unusual presentation and review of the literature.pdf
  5. Tetralogy of Fallot and abnormal coronary artery- use of a prosthetic conduit is outdated.pdf
  6. 3D-Printed Models for Surgical Planning in Complex Congenital Heart Diseases- A Systematic Review.pdf
  7. Double orifice and atrioventricular septal defect- dealing with the zone of apposition.pdf
  8. Meaningful and feasible composite clinical worsening definitions in paediatric pulmonary arterial hypertension- An analysis of the TOPP registry.pdf
  9. Risk factors of mortality and recoarctation after coarctation repair in infancy.pdf
  10. Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post–Fontan procedure- Rationale and design of a prospective, randomized trial (the UNIVERSE study).pdf
  11. Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies. (to be uploaded)
  1. Perfusion Study Helps in the Management of the Intraseptal Course of an Anomalous Coronary Artery.pdf
  1. Transcatheter pulmonary valvuloplasty in neonates with pulmonary atresia and intact ventricular septum.pdf
  1. Intra-atrial re-entrant tachycardia around atretic tricuspid annulus.pdf
  1. Posterolateral Line An Alternative to Cavotriscupid Isthmus Ablation for Treatment of Peritricuspid Re-Entry in Patients With Dextro-Transposition of the Great Arteries and Mustard Operation.pdf
  1. Treatment of pediatric pulmonary arterial hypertension A focus on the NO‐sGC‐cGMP pathway.pdf
  2. Nakata index above 1500mm2m2 predicts death in absent pulmonary valve syndrome.pdf
  3. Pharmacokinetics and safety of tadalafil in a paediatric population with pulmonary arterial hypertension- A multiple ascending‐dose study.pdf
  4. Standardised imaging pipeline for phenotyping mouse laterality defects and associated heart malformations at multiple scales and multiple stages.pdf
  1. Aortic atresia and interrupted aortic arch communicating through external carotid anastomosis.pdf
  1. FLNC pathogenic variants in patients with cardiomyopathies Prevalence and genotype-phenotype correlations.pdf
  1. Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest.
  2. Ascending aorta and aortic root replacement (with or without valve sparing) in early childhood.pdf
  3. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension.pdf
  4. Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr)- results from three multicentre, single-arm, phase 2 studies.pdf
  5. Percutaneous closure of patent ductus arteriosus in premature infants- A French national survey.pdf
  6. Randomised controlled trial of rivaroxaban compared to standard anticoagulants for the treatment of acute venous thromboembolism in children.pdf 
  7. Congenitally corrected transposition of the great arteries- is it really a transposition? An anatomical study of the right ventricular septal surface.pdf 
  8. Merged Bilateral Arterial Duct and Circumflex Retroesophageal Right Aortic Arch in a Fetus with Normal Intracardiac Anatomy..pdf
  9. Recommendations from the AEPC for training in pulmonary hypertension.pdf
  10. Pulmonary hypertension after bone marrow transplantation in children.pdf
  11. CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose
  1. Single-Shot Cold Histidine-Tryptophan-Ketoglutarate Cardioplegia for Long Aortic Cross-Clamping Durations in Neonates .pdf
  2. Perioperative Goal Directed Fluid and Hemodynamic Therapy with Echocardiography in Pediatric Congenital Heart Disease- A Study Protocol.pdf
  3. Cardiac performance assessment during cardiopulmonary exercise test can improve the management of children with repaired congenital heart disease.
  4. Neopulmonary Outflow Tract Obstruction Assessment by 4D Flow MRI in Adults With Transposition of the Great Arteries After Arterial Switch Operation.pdf
  5. 4D flow MRI versus conventional 2D for measuring pulmonary flow after Tetralogy of Fallot repair..pdf
  6. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children- a randomised, controlled, phase 3 trial..pdf
  7. Phenotype and outcome of PAH patients carrying a TBX4 mutation.
  8. Right ventricular outflow tract prestenting with AndraStent XXL before percutaneous pulmonary valve implantation.pdf
  9. Temporal trends in the use of targeted temperature management after cardiac arrest and association with outcome- insights from the Paris Sudden Death Expertise Centre..pdf
  10. Sudden Cardiac Arrest in Adults With Congenital Heart Disease..pdf
  11. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort.
  12. Administration of gamma-hydroxybutyrate instead of beta- hydroxybutyrate to a liver transplant recipient suffering from propionic acidemia and cardiomyopathy- A case report on a medication prescribing error.pdf
  13. Comparative pharmacokinetics of tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus to prolonged-release tacrolimus formulation..pdf
  14. Efficacy and safety of prolonged-release tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus.pdf
  15. Management and Outcomes of Neonatal Arteriovenous Brain Malformations with Cardiac Failure- A 17 Years' Experience in a Tertiary Referral Center.pdf
  16. Impact of Sophrology on cardiopulmonary fitness in teenagers and young adults with a congenital heart disease- The SOPHROCARE study rationale, design and methods..pdf
  17. Efficacy of phosphodiesterase type 5 inhibitors in univentricular congenital heart disease- the SV- INHIBITION study design.pdf.
  18. Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation.pdf
  19. Imaging features of complete congenital atresia of left coronary artery.pdf
  20. Children Born with Congenital Heart Defects and Growth Restriction at Birth- A Systematic Review and Meta-Analysis.pdf
  1. Prenatal Diagnosis of Aorto-Left Ventricular Tunnel With Dysplastic Bicuspid Aortic Valve- From Fetal Cardiac Failure to Favorable Outcome.pdf
  2. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease.pdf
  3. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris.pdf
  4. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic
  5. Position paper concerning the competence, performance and environment required for the practice of ablation in children and in congenital heart disease.pdf
  6. An International Multi-Center Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2- Catecholaminergic Polymorphic Ventricular Tachycardia.
  7. Inherited Cardiomyopathies Revealed by Clinically Suspected Myocarditis: Highlights From Genetic Testing.
  8. Catheter ablation of intra-atrial reentrant/focal atrial tachycardia in adult congenital heart disease: Value of final programmed atrial stimulation.
  9. Hybrid perventricular muscular ventricular septal defect closure using the new multi-functional occluder.pdf.
  10. Chronic Kidney Disease in Adolescents after Surgery for Congenital Heart Disease.pdf
  11. Three-dimensional geometry of coronary arteries after arterial switch operation for transposition of the great arteries and late coronary events.
  12. Transhepatic atrial septal defect closure- simple way to achieve haemostasis in a patient with important co-morbidities..pdf
  13. Anomalous aortic origin of coronary arteries: an alternative to the unroofing strategy.
  14. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children.pdf
  15. 4D flow cardiac magnetic resonance in children and adults with congenital heart disease- Clinical experience in a high volume center.pdf
  16. Cardiac computed tomography angiography in the paediatric population.pdf
  17. Geleophysic and acromicric dysplasias- natural history, genotype–phenotype correlations, and management guidelines from 38 cases.pdf
  18. Health-related quality of life correlates with time in therapeutic range in children on anticoagulants with International Normalised Ratio self-monitoring..pdf
  19. Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE).pdf
  20. A case series of transcatheter Potts Shunt creation in a pediatric population affected with refractory pulmonary artery hypertension- focus on the role of ECMO..pdf
  21. Upfront triple combination therapy in severe paediatric pulmonary arterial hypertension.
  22. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19)- a multicentre cohort.pdf
  23. Autoantibodies against type I IFNs in patients with life-threatening COVID-19.pdf
  24. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.pdf
  25. 2020 ESC Guidelines for the management of adult congenital heart disease.pdf
  26. Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy..pdf
  27. Society for Cardiovascular Magnetic Resonance (SCMR) recommended CMR protocols for scanning patients with active or convalescent phase COVID-19 infection.pdf
  28. Addition of Corticosteroids to Immunoglobulins Is Associated With Recovery of Cardiac Function in Multi-Inflammatory Syndrome in Children.pdf
  29. Parcours prénatal devant une malformation pour laquelle un traitement in utero émergent est disponible.
  30. Unilateral branch pulmonary artery origin from a solitary arterial trunk with major aortopulmonary collaterals to the contralateral lung: anatomic and developmental considerations.
  31. Potts anastomosis in children with severe pulmonary arterial hypertension and atrial septal defect.pdf
  32. Pulmonary hypertension associated with congenital heart block and neonatal lupus syndrome.pdf
  33. Outcomes after common arterial trunk repair: impact of surgical technique.
  34. Predictors of low exercise cardiac output in patients with severe pulmonic regurgitation.pdf
  35. Multisystem Inflammatory Syndrome in Children: An International Survey.
  36. Cardiac MRI Prediction of Recovery in Children With Acute Myocarditis.
  37. Sudden cardiac arrest in an epicardial paced-dependent child: watch out, it's a pitfall!
  38. Association between SARS-CoV-2 infection and Kawasaki-like multisystem inflammatory syndrome- a retrospective matched case–control study, Paris, France, April to May 2020.pdf
  39. Longitudinal Analysis of Fetal Ventricular Rate for Risk Stratification in Immune Congenital Heart Block..pdf
  40. Prenatal diagnosis of anomalous connection of the inferiorcaval vein to the left atrium associated with common arterial trunk.pdf
  41. Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT).pdf
  42. Evolution of acute myocarditis in a pediatric population- An MRI based study..pdf
  43. Propositions du GFHT pour la gestion des discordances entre l’International normalized ratio mesuré au laboratoire et en automesure [GFHT proposals for management of discordance between the International normalized ratio measured in the laboratory and by self-testing].
  44. Etiology of intracerebral hemorrhage in children: cohort study, systematic review, and meta-analysis.
  45. Endovascular stenting of blunt aortic isthmus rupture in a 5-year-old child.
  46. Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection.pdf
  47. Preliminary Experience With the New AmplatzerTM TrevisioTM Delivery System in Transcatheter Atrial Septal Defect Closures in Children.pdf
  48. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.pdf
  49. Association between prophylactic angiotensin-converting enzyme inhibitors and overall survival in Duchenne muscular dystrophy-analysis of registry data.
  50. Impact of aortic arch curvature in flow haemodynamics in patients with transposition of the great arteries after arterial switch operation.pdf
  51. Fast-track virtual reality for cardiac imaging in congenital heart disease.pdf.
  52. Gastrointestinal Symptoms Followed by Shock in a Febrile 7-Year-Old Child during the COVID-19 Pandemic.pdf.
  53. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children.pdf.
  54. Responses to exercise training in patients with heart failure. Analysis by oxygen transport steps..pdf
  55. Catheter ablation in adults with congenital heart disease - A 15-year perspective from a tertiary centren.pdf
  56. Outcomes of sustained fetal tachyarrhythmias after transplacental treatment.pdf
  57. SARS-CoV-2-related MIS-C- A key to the viral and genetic causes of Kawasaki disease?.pdf
  58. Transplantation for pulmonary arterial hypertension with congenital heart.pdf.
  59. Preliminary Experience With the New Amplatzer™ Trevisio™ Delivery System in Transcatheter Atrial Septal Defect Closures in Children.pdf
  60. Mortality and functional outcome after pediatric intracerebral hemorrhage: cohort study and meta-analysis.
  61. Ross procedure or complex aortic valve repair using pericardium in children: A real dilemma.
  62. Mid-Term Outcomes Following Percutaneous Pulmonary Valve Implantation Using the "Folded Melody Valve" Technique.pdf
  63. Aorta-to-right ventricle neoshunt closure using an Amplatzer Duct Occluder II device.pdf
  64. Continuous positive airway pressure improves work of breathing in pediatric chronic heart failure.pdf
  65. Predicting the risk of infant mortality for newborns operated for congenital heart defects- A population-based cohort (EPICARD) study of two post-operative predictive scores.pdf
  66. Endothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children With Shock.pdf.
  67. Abnormal origin of the left pulmonary artery from the descending aorta and heterotaxy syndrome- an undescribed phenotypic association.pdf
  68. Outcomes of sustained fetal tachyarrhythmias after transplacental treatment.pdf.
  69. Prevalence of Growth Restriction at Birth for Newborns With Congenital Heart Defects- A Population-Based Prospective Cohort Study EPICARD.pdf
  70. Long-term Neurodevelopmental Outcomes of Children with Congenital Heart Defects.pdf
  71. Polyclonal expansion of TCR Vbeta 21.3+CD4+ and CD8+ T cells is a hallmark of Multisystem Inflammatory Syndrome in Children.pdf
  72. Effect of medical treatment on heart failure incidence in patients with a systemic right ventricle.
  73. Atrial flutter catheter ablation in adult congenital heart diseases.pdf
  74. Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary Hypertension.pdf
  75. Health‑related quality of life and physical activity in children with inherited cardiac arrhythmia or inherited cardiomyopathy -the prospective multicentre controlled QUALIMYORYTHM study rationale design and methods.pdf
  76. Heterotaxy: fluctuat nec mergitur.
  77. Transcatheter patent arterial duct closure in premature infants- A new technique to ease access to the patent arterial duct, with particular benefit for the tricuspid valve..pdf
  78. A retrospective analysis of discordances between international normalized ratio (INR) self-testing and INR laboratory testing in a pediatric patient population.
  79. Multifactorial origin of pulmonary hypertension in a child with congenital heart disease, Down syndrome, and BMPR-2 mutation..pdf
  80. Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension- phase 3 randomized, double-blind placebo-controlled study..pdf
  81. Consensus Guidelines for the Prevention and Management of Periprocedural Complications of Transcatheter Patent Ductus Arteriosus Closure with the Amplatzer Piccolo Occluder in Extremely Low Birth Weight Infants..pdf
  82. Nomenclature for Pediatric and Congenital Cardiac Care Unification of Clinical and Administrative Nomenclature.pdf - The 2021 International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Revision of the International Classification of Diseases (ICD-11).
  83. Exposure to low-dose ionising radiation from cardiac catheterisation and risk of cancer- the COCCINELLE study cohort profile..pdf
  84. Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary Hypertension..pdf
  85. Late Pediatric Mechanical Thrombectomy for Embolic Stroke as Bridge Reinforcement From LVAD to Heart Transplantation.pdf.
  86. Heart Development and Congenital Structural Heart Defects.pdf.
  87. A monocyte:dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis.pdf.
  88. Respiratory morbidity in children with congenital heart disease.pdf
  89. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.pdf
  90. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.pdf
  91. PPA2-associated sudden cardiac death- extending the clinical and allelic spectrum in 20 new families.pdf
  92. Mid-Term Outcomes Following Percutaneous Pulmonary Valve Implantation Using the “Folded Melody Valve” Technique.pdf
  93. Atrial flutter catheter ablation in adult congenital heart diseases.pdf
  94. Impact of Pulmonary Valve Replacement on Ventricular Arrhythmias in Patients With Tetralogy of Fallot and Implantable Cardioverter-Defibrillator.pdf
  95. Study design and rationale of the pAtients pResenTing with cOngenital heaRt dIseAse Register (ARTORIA-R).pdf.
  96. Cardiovascular events in perimembranous ventricular septal defect with left ventricular volume overload: a French prospective cohort study (FRANCISCO).
  97. Impacts of prenatal diagnosis of congenital heart diseases on outcomes.pdf.
  98. Hemodynamic and prognostic impact of the diastolic pulmonary arterial pressure in children with pulmonary arterial hypertension-a registry-based analysis..pdf
  99. A New Solution For Stenting Large Right Ventricular Outflow Tracts Before Transcatheter Pulmonary Valve Replacement.
  100. Diagnostic Value of 18F-Fluorodeoxyglucose Positron Emission Tomography Computed Tomography in Prosthetic Pulmonary Valve Infective Endocarditis.pdf
  101. External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy.pdf.
  102. Challenging indication of cardioverter defibrillator implantation after sudden cardiac arrest in the very young.pdf
  103. Anterior Minithoracotomy vs. Transcatheter Closure of Patent Ductus Arteriosus in Very Preterm Infants.pdf
  104. Spontaneous Closure of the Arterial Duct after Transcatheter Closure Attempt in Preterm Infants.pdf
  105. Common Arterial Trunk Associated with Functionally Univentricular Heart- Anatomical Study and Review of the Literature.pdf
  106. Common Genetic Variants Contribute to Risk of Transposition of the Great Arteries.pdf
  107. Promising PTFE-coating technology of Optimus-CVS™ stents.pdf
  108. Prevalence of Venovenous Shunting and High-Output State Quantified with 4D Flow MRI in Patients with Fontan Circulation.pdf
  109. Quality of Life of Children Born with a Congenital Heart Defect.pdf
  110. Myocardial involvement in children with post-COVID multisystem inflammatory syndrome- a cardiovascular magnetic resonance based multicenter international study—the CARDOVID registry.pdf
  111. Accuracy and impact of prenatal diagnosis of common arterial trunk
  112. Clinical Presentation and Heart Failure in Children With Arrhythmogenic Cardiomyopathy
  113. External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy.
  114. Embolization of vascular abnormalities in children with congenital heart diseases using medtronic micro vascular plugs
  115. Indications and outcomes of cardiac catheterization following congenital heart surgery in children
  116. Modified safety techniques for transcatheter repair of superior sinus venosus defects with partial anomalous pulmonary venous drainage using a 100-mm Optimus-CVS® covered XXL stent
  117. Multisystem inflammatory syndrome in children: Inputs of BNP, NT-proBNP and Galectin-3
  118. Multifactorial pulmonary hypertension in infantile scimitar syndrome.pdf
  119. Inferior sinus venosus defect and anomalous hepatic venous return to the coronary sinus leading to an Eisenmenger syndrome.
  120. Incidence, Risk Factors, and Outcomes of Atrial Arrhythmias in Adult Patients With Atrioventricular Septal Defect.
  121. Cardiac resynchronization therapy in patients with congenital heart disease and systemic right ventricle.
  122. Transcatheter closure of an acquired post-operative aorta to right ventricle shunt in a child with complex univentricular heart.
  123. Submitral aneurysm communicating with coronary sinus in a child.
  124. Biallelic alterations in PLXND1 cause common arterial trunk and other cardiac malformations in humans.
  125. Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-C.pdf
  126. Health Outcome of 215 Mothers of Children with Autoimmune Congenital Heart Block Analysis of the French Neonatal Lupus Syndrome Registry.pdf
  127. Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy.pdf
  128. Valvuloplastie aortique fœtale pour sténose aortique critique : indications, technique et devenir postnatal
  129. An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants.pdf
  130. Epigenetics and congenital heart diseases.pdf
  131. Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy.pdf
  132. Prognostic factors in hypertrophic cardiomyopathy in children- An MRI based study.pdf
  133. Natural history of Myhre syndrome.pdf
  134. Amiodarone/N-desethylamiodarone population pharmacokinetics in paediatric patients.
  135. Word of caution: Severe aortic valve injury linked to retrograde closure of perimembranous ventricular septal defects.
  136. Three centers experience with device closure of congenital Gerbode-type perimembranous ventricular septal defects.
  137. The pivotal role of tricuspid regurgitation in the failing systemic right ventricle: The "chicken and egg story".
  138. Percutaneous Edge-to-Edge Repair for Systemic Atrioventricular Valve Regurgitation in Patients With Congenital Heart Disease- The First Descriptive Cohort..pdf
  139. PPA2-associated sudden cardiac death - extending the clinical and allelic spectrum in 20 new families.pdf
  140. Long-term outcomes of transcatheter Potts shunt in children with suprasystemic pulmonary arterial hypertension.pdf
  141. Riociguat in children with pulmonary arterial hypertension The PATENT–CHILD study.pdf
  142. Exercise electrocardiogram for risk-based screening of severe residual coronary lesion in children after coronary surgery.pdf
  143. Transcatheter interventions in patients with a Fontan circulation: Current practice and future developments.
  144. Atrial fibrillation in Ebstein anomaly: weathering the storm.
  145. Rapid ventricular tachycardia in patients with tetralogy of Fallot and implantable cardioverter-defibrillator: Insights from the DAI-T4F nationwide registry.
  146. Sex Differences in Outcomes of Tetralogy of Fallot Patients With Implantable Cardioverter-Defibrillators.
  147. Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillator Therapy in Patients With Tetralogy of Fallot.
  148. Tachyarrhythmias in Congenital Heart Diseases: From Ion Channels to Catheter Ablation.
  149. Catheter Ablation of Atrioventricular Nodal Reentrant Tachycardia in Patients With Congenital Heart Disease.
  150. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children.
  151. Long term follow-up after haematopoietic stem cell transplantation for mucopolysaccharidosis type I-H: a retrospective study of 51 patients.
  152. Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease.
  153. Baseline Characteristics of Pediatric Patients With Heart Failure Due to Systemic Left Ventricular Systolic Dysfunction in the PANORAMA-HF Trial.pdf
  154. Two-to-one Purkinje-to-myocardium activation during ventricular fibrillation associated with hypertrophic cardiomyopathy.pdf
  155. Early Mortality in Infants Born with Neonatally Operated Congenital Heart Defects and Low or Very-Low Birthweight.pdf
  156. Multicentre experience with Optimus balloon-expandable cobalt-chromium stents in congenital heart disease interventions.pdf
  157. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children.pdf
  158. Long term follow-up after haematopoietic stem cell transplantation for mucopolysaccharidosis type I-H- a retrospective study of 51 patients.pdf
  159. Epicardial vs. transvenous implantable cardioverter defibrillators in children.pdf
  160. Transvenous retrograde thoracic duct embolization for effective treatment of recurrent plastic bronchitis after fontan palliation.pdf
  161. Expanding the phenome and variome of the ROBO-SLIT pathway in congenital heart defects- toward improving the genetic testing yield of CHD.pdf
  162. Early spontaneous closure of large arterial ducts in two term neonates with Ebstein anomaly after failed attempts of transcatheter closure.
  163. 4D flow magnetic resonance imaging to assess right ventricular outflow tract in patients undergoing transcatheter pulmonary valve replacement.
  164. Long-term Outcome of Children with Newly Diagnosed Pulmonary Arterial Hypertension.pdf 
  165. Monitoring of Hemodynamics With Right Heart Catheterization in Children With Pulmonary Arterial Hypertension.pdf
  166. Maladie de Kawasaki infantile : diagnostic et prise en charge [Diagnosis and management of Kawasaki disease]. 
  167. Discordance between 2D and 4D flow in the assessment of pulmonary regurgitation severity: a right ventricular remodeling follow-up study.
  168. Origin of congenital coronary arterio-ventricular fistulae from anomalous epicardial and myocardial development. 
  169. Bicuspid valve repair outcomes are improved with reduction and stabilization of sinotubular junction and annulus with external annuloplasty.
  170. « Mets la main sur mon cœur, Et vois comme il se trouble » – un pseudo-chylopéricarde ? [Chylopericardium or contamination by injectable lipid emulsion?].
  171. Severe COVID-19 evolving towards organizing pneumonia in a pediatric lung transplant recipient.
  172. Failure to post-dilate BeSmooth peripheral stents to adult vessel size diameters during benchside tests. 
  173. Systematic Electrophysiological Study Prior to Pulmonary Valve Replacement in Tetralogy of Fallot-A Prospective Multicenter Study.pdf
  174. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
  175. Hydroxychloroquine sulfate: A novel treatment for lipin-1 deficiency?
  176. Neuroinflammatory Disease following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children.
  177. Two pediatric cases of multisystem inflammatory-like syndrome following COVID-19 vaccination.
  178. Severe Bacterial Infection Initially Misdiagnosed as MIS-C: Caution Needed.
  179. Percutaneous stent implantation for occluded central shunts in adults: A case report and review of current evidence.
  180. Multisystem inflammatory syndrome in children during the COVID-19 waves- data from the Juvenile Inflammatory Rheumatism cohort.pdf
  181. Rightward imbalanced pulmonary perfusion predicts better exercise stroke volume in children after Fallot repair.
  182. Motor outcomes in patients with infantile and juvenile Pompe disease: Lessons from neurophysiological findings.
  183. Morphological and genetic causes of fetal cardiomyopathies.
  184. 2023 ESC Guidelines for the management of cardiomyopathies.
  185. Pediatric heart failure withpreserved ejection fraction, a review.pdf
  186. Resection and double pericardial patch repair of a congenital aneurysm of the mitral-aortic intervalvular fibrosa.
  187. Congenital disconnection of the pulmonary arteries.
  188. Lympho-hematopoietic malignancies risk after exposure to low dose ionizing radiation during cardiac catheterization in childhood.
  189. Transcatheter Management of Pulmonary Sequestrations in Children.pdf
  190. Outcomes of manually modified microvascular plugs to pulmonary flow restrictors in various congenital heart lesions.
  191. Improvised bespoke technique for atrial septostomy in the shortage of atrioseptostomy balloon catheters. 
  192. Management for atrial arrhythmias in adults with complex congenital heart disease.
  193. Catheter ablation of atrial tachyarrhythmias in patients with atrioventricular septal defect.
  194. Outcomes after aortic coarctation repair in neonates weighing less than 2000 g.
  195. Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry.
  196. Identification of Greb1l as a genetic determinant of crisscross heart in mice showing torsion of the heart tube by shortage of progenitor cells.
  197. Transcatheter Closure of Superior Sinus Venosus Defects.
  198. Acquired cardiovascular disease in adults with congenital heart disease.
  199. Proof of Concept: A New Solution for Low-Profile Transcatheter Implantation of Optimus-L Stents in Small Children.
  200. Aorta Without Coronary Arteries: Anatomic Variants of a Rare Malformation.
  201. Risk factors for serious adverse events related to vitamin K antagonists in children with congenital or acquired heart disease: a prospective cohort study.
  202. Successful percutaneous treatment of perinatal complete left coronary thrombotic occlusion.
  203. Outcomes of coronary artery obstructions after the arterial switch operation for transposition of the great arteries.
  204. Type 3 long QT syndrome: is the effectiveness of treatment with beta-blockers population-specific? 
  205. Diagnosis of Menke-Hennekam syndrome by prenatal whole exome sequencing and review of prenatal signs.
  206. Management for atrial arrhythmias in adults with complex congenital heart disease.
  207. Sudden cardiac arrest in adult congenital heart disease: a challenge to be tackled.
  208. Subcutaneous Implantable Cardioverter-Defibrillators in Patients With Congenital Heart Disease.
  209. Rationale and Design of the Multicenter Catheter Ablation of Ventricular Tachycardia Before Transcatheter Pulmonary Valve Replacement in Repaired Tetralogy of Fallot Study.
  210. Sinus rhythm QRS morphology reflects right ventricular activation and anatomical ventricular tachycardia isthmus conduction in repaired tetralogy of Fallot.
  211. Ventricular Arrhythmias in Adults With Congenital Heart Disease, Part I: JACC State-of-the-Art Review.
  212. Ventricular Arrhythmias in Adults With Congenital Heart Disease, Part II: JACC State-of-the-Art Review.
  213. Cerebral embolic protection during transcatheter stent expansion of restrictive extra-cardiac Fontan conduit.
  214. Outcomes of aortic valve repair in children stratified by complexity: Which outcome for which lesion?
  215. Infant congenital heart disease prevalence and mortality in French Guiana: a population-based study.
  216. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection. 
  217. Postnatal outcome following fetal aortic valvuloplasty for critical aortic stenosis.
  218. Three-Decade Experience with Management of Coronary Artery Fistulas in Children. 
  219. Postoperative catheter thrombaspiration to open an occluded right ventricle-to-pulmonary artery conduit in child.
  220. Increased aortic pressures and pulsatile afterload components promote concentric left ventricular remodeling in adults with transposition of the great arteries and arterial switch operation.
  221. Successful percutaneous treatment of perinatal complete left coronary thrombotic occlusion.
  222. Renal function after ductus arteriosus transcatheter closure with or without angiography in very preterm infants.
  223. Early hybrid cardiac rehabilitation in congenital heart disease: the QUALIREHAB trial.
  224. Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus.
  225. Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry.
  226. Predicting Long-Term Childhood Survival of Newborns with Congenital Heart Defects: A Population-Based, Prospective Cohort Study (EPICARD).
  227. Prophylactic Pulmonary Artery Banding in Pediatric Dilated Cardiomyopathy: An Additional Therapeutic Option.
  228. Pulmonary vascular phenotype identified in patients with GDF2 (BMP9) or BMP10variants: an international multicentre study.
  229. Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry.
  230. Application of a modified clinical classification for pulmonary arterial hypertension associated with congenital heart disease in children: emphasis on atrial septal defects and transposition of the great arteries. An analysis from the TOPP registry.
  231. Neurodevelopmental outcomes of preterm and growth-restricted neonate with congenital heart defect: a systematic review and meta-analysis. 
  232. Long-term results after the réparation à l'étage ventriculaire procedure for transposition of the great arteries and double-outlet right ventricle with pulmonary stenosis. 
  233. Human Genetics of d-Transposition of Great Arteries.
  234. Ventricular Septal Defects: Molecular Pathways and Animal Models. 
  235. Doppler echocardiography for surveillance of acute cardiac allograft rejection: a 28-year single-center experience.
  236. Organisation of paediatric echocardiography laboratories and governance of echocardiography services and training in Europe: current status, disparities and potential solutions. A survey from the Association for European Paediatric and Congenital Cardiology (AEPC) imaging working group.
  237. Prevalence and Significance of Rare Genetic Variants in AKAP9 in Inherited Cardiac Diseases.
  238. Pulmonary Hypertension Induced by Right Pulmonary Artery Occlusion: Hemodynamic Consequences of Bmpr2 Mutation.
  239. Atrial Flow Regulator Implantation for Interatrial Shunt Patency in 12 Infants ≤ 5 kg: A Pilot Study.
  240. Systematic analysis of SCN5A variants associated with inherited cardiac diseases.
  241. Prediction of Positive Genetic Testing for Arrhythmogenic Left Ventricular Cardiomyopathy.
  242. BeGraft Aortic Stents: A European Multi-Centre Experience Reporting Acute Safety and Efficacy Outcomes for the Treatment of Vessel Stenosis in Congenital Heart Diseases.
  243. Embracing the challenges of neonatal and paediatric pulmonary hypertension.
  244. Impact of the transpulmonary pressure on right ventricle impairment incidence during acute respiratory distress syndrome: a pilot study in adults and children.
  245. Clinical impact of genetic testing in a large cohort of pediatric cardiomyopathies.
  246. Lymphatic Disorder Management in Pediatric Patients With Congenital Heart Disease in European Pediatric Cardiology Centers: Current Status, Disparities, and Future Considerations. 
  247. Pulmonary hypertension in patients carrying FLNA loss-of-function variants. 
  248. Clinical impact of circulating biomarkers in prediction of adverse cardiac events in patients with congenital heart disease. A systematic review.
  249. Device Closure of Hemodynamically Significant Patent Ductus Arteriosus in Premature Infants. 
  250. Do we need to change names to better understand hearts with deficient ventricular septation?
  251. CMR Predictors of Ventricular Arrhythmias Inducibility Before Pulmonary Valve Replacement in Tetralogy of Fallot.
  252. An exceptional anomaly of the coronary venous drainage: anatomic description.
  253. Beyond genomic studies of congenital heart defects through systematic modelling and phenotyping.
  254. Acute respiratory failure due to pulmonary exacerbation in children with cystic fibrosis admitted in a pediatric intensive care unit: outcomes and factors associated with mortality.
  255. Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors.
  256. Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness.
  257. Evidence and unresolved questions in pulmonary hypertension: Insights from the 5th French Pulmonary Hypertension Network Meeting.
  258. Deep phenotyping of unaffected carriers of pathogenic BMPR2 variants screened for pulmonary arterial hypertension.